发明名称 |
Use of deferiprone and methods to treat and/or prevent Friedreich Ataxia resulting from intracellular mishandling of iron |
摘要 |
A therapeutically effective amount of deferiprone or deferasirox or physiologically acceptable salts thereof for the prevention, stabilization, treatment, or reversal of iron-induced FRDA disease in patients resulting from mitochondrial iron-induced damage to preferentially reduce the iron stores in the mitochondria. Also for the treatment of other conditions affecting the brain where a key element in the generation of the resultant pathology is the intracellular mishandling of iron.
|
申请公布号 |
US2007197649(A1) |
申请公布日期 |
2007.08.23 |
申请号 |
US20070708322 |
申请日期 |
2007.02.21 |
申请人 |
MUNNICH ARNOLD;SPINO MICHAEL;CABANTCHIK IOAV |
发明人 |
MUNNICH ARNOLD;SPINO MICHAEL;CABANTCHIK IOAV |
分类号 |
A61K31/195 |
主分类号 |
A61K31/195 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|